Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: QRONO, INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-09-30 to 2025-09-29
Current total value of award: $599945
Description: SCREENING FOR TOLEROGENIC ADJUVANTS TO ENHANCE ANTIGEN SPECIFIC IMMUNOTHERAPY FOR CELIAC DISEASE.